Reports and Markets

View Report

Global Eye Drug Market Insights, Forecast to 2025

Publisher:    QYResearch

No. of Pages:    125

Report Code:   RnM2448841

1-user License :    $3,900.00

Site License :    $5,850.00

Enterprise License :    $7,800.00

Table of Content

1 Study Coverage

1.1 Eye Drug Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
- 1.4.1 Global Eye Drug Market Size Growth Rate by Product
- 1.4.2 Drops
- 1.4.3 Tablet & Capsule
1.5 Market by End User
- 1.5.1 Global Eye Drug Market Size Growth Rate by End User
- 1.5.2 Glaucoma
- 1.5.3 Retinal Disease
- 1.5.4 Bacterial?Infection
- 1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary

2.1 Global Eye Drug Market Size
- 2.1.1 Global Eye Drug Revenue 2014-2025
- 2.1.2 Global Eye Drug Sales 2014-2025
2.2 Eye Drug Growth Rate by Regions
- 2.2.1 Global Eye Drug Sales by Regions
- 2.2.2 Global Eye Drug Revenue by Regions

3 Breakdown Data by Manufacturers

3.1 Eye Drug Sales by Manufacturers
- 3.1.1 Eye Drug Sales by Manufacturers
- 3.1.2 Eye Drug Sales Market Share by Manufacturers
- 3.1.3 Global Eye Drug Market Concentration Ratio (CR5 and HHI)
3.2 Eye Drug Revenue by Manufacturers
- 3.2.1 Eye Drug Revenue by Manufacturers (2014-2019)
- 3.2.2 Eye Drug Revenue Share by Manufacturers (2014-2019)
3.3 Eye Drug Price by Manufacturers
3.4 Eye Drug Manufacturing Base Distribution, Product Types
- 3.4.1 Eye Drug Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Eye Drug Product Type
- 3.4.3 Date of International Manufacturers Enter into Eye Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

4.1 Global Eye Drug Sales by Product
4.2 Global Eye Drug Revenue by Product
4.3 Eye Drug Price by Product

5 Breakdown Data by End User

5.1 Overview
5.2 Global Eye Drug Breakdown Data by End User

6 North America

6.1 North America Eye Drug by Countries
- 6.1.1 North America Eye Drug Sales by Countries
- 6.1.2 North America Eye Drug Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
6.2 North America Eye Drug by Product
6.3 North America Eye Drug by End User

7 Europe

7.1 Europe Eye Drug by Countries
- 7.1.1 Europe Eye Drug Sales by Countries
- 7.1.2 Europe Eye Drug Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
7.2 Europe Eye Drug by Product
7.3 Europe Eye Drug by End User

8 Asia Pacific

8.1 Asia Pacific Eye Drug by Countries
- 8.1.1 Asia Pacific Eye Drug Sales by Countries
- 8.1.2 Asia Pacific Eye Drug Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
8.2 Asia Pacific Eye Drug by Product
8.3 Asia Pacific Eye Drug by End User

9 Central & South America

9.1 Central & South America Eye Drug by Countries
- 9.1.1 Central & South America Eye Drug Sales by Countries
- 9.1.2 Central & South America Eye Drug Revenue by Countries
- 9.1.3 Brazil
9.2 Central & South America Eye Drug by Product
9.3 Central & South America Eye Drug by End User

10 Middle East and Africa

10.1 Middle East and Africa Eye Drug by Countries
- 10.1.1 Middle East and Africa Eye Drug Sales by Countries
- 10.1.2 Middle East and Africa Eye Drug Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
10.2 Middle East and Africa Eye Drug by Product
10.3 Middle East and Africa Eye Drug by End User

11 Company Profiles

11.1 Pfizer
- 11.1.1 Pfizer Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Pfizer Eye Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Pfizer Eye Drug Products Offered
- 11.1.5 Pfizer Recent Development
11.2 Novartis
- 11.2.1 Novartis Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Novartis Eye Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Novartis Eye Drug Products Offered
- 11.2.5 Novartis Recent Development
11.3 bausch Lomb
- 11.3.1 bausch Lomb Company Details
- 11.3.2 Company Business Overview
- 11.3.3 bausch Lomb Eye Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 bausch Lomb Eye Drug Products Offered
- 11.3.5 bausch Lomb Recent Development
11.4 Laboratoire Riva
- 11.4.1 Laboratoire Riva Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Laboratoire Riva Eye Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Laboratoire Riva Eye Drug Products Offered
- 11.4.5 Laboratoire Riva Recent Development
11.5 Jamp Pharma
- 11.5.1 Jamp Pharma Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Jamp Pharma Eye Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Jamp Pharma Eye Drug Products Offered
- 11.5.5 Jamp Pharma Recent Development
11.6 Fresenius
- 11.6.1 Fresenius Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Fresenius Eye Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Fresenius Eye Drug Products Offered
- 11.6.5 Fresenius Recent Development
11.7 Teva Pharmaceutical?
- 11.7.1 Teva Pharmaceutical? Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Teva Pharmaceutical? Eye Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Teva Pharmaceutical? Eye Drug Products Offered
- 11.7.5 Teva Pharmaceutical? Recent Development
11.8 SANDOZ
- 11.8.1 SANDOZ Company Details
- 11.8.2 Company Business Overview
- 11.8.3 SANDOZ Eye Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 SANDOZ Eye Drug Products Offered
- 11.8.5 SANDOZ Recent Development
11.9 Greenstone
- 11.9.1 Greenstone Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Greenstone Eye Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Greenstone Eye Drug Products Offered
- 11.9.5 Greenstone Recent Development
11.10 Mylan
- 11.10.1 Mylan Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Mylan Eye Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Mylan Eye Drug Products Offered
- 11.10.5 Mylan Recent Development
11.11 GE Medical
11.12 Mint Pharmaceuticals
11.13 Laboratoires Thea
11.14 Taj Pharmaceuticals
11.15 Actavis
11.16 APOTEX
11.17 Sun Pharma

12 Future Forecast

12.1 Eye Drug Market Forecast by Regions
- 12.1.1 Global Eye Drug Sales Forecast by Regions 2019-2025
- 12.1.2 Global Eye Drug Revenue Forecast by Regions 2019-2025
12.2 Eye Drug Market Forecast by Product
- 12.2.1 Global Eye Drug Sales Forecast by Product 2019-2025
- 12.2.2 Global Eye Drug Revenue Forecast by Product 2019-2025
12.3 Eye Drug Market Forecast by End User
12.4 North America Eye Drug Forecast
12.5 Europe Eye Drug Forecast
12.6 Asia Pacific Eye Drug Forecast
12.7 Central & South America Eye Drug Forecast
12.8 Middle East and Africa Eye Drug Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

14.1 Value Chain Analysis
14.2 Eye Drug Customers
14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
16.2 Author Details